View
32
Download
0
Category
Tags:
Preview:
DESCRIPTION
Review Considerations on Source Plasma Vaccination Programs. Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009. Outline. Considerations on how to submit for a vaccination program when using: Licensed vaccines according to package insert - PowerPoint PPT Presentation
Citation preview
CC BBEE RR
Review Considerations onSource Plasma
Vaccination ProgramsJudy Ellen CiaraldiBS, MT(ASCP)SBB, CQA(ASQ)
CBER, OBRR, DBA
September 16, 2009
2
CC BBEE RR
Outline
• Considerations on how to submit for a vaccination program when using:• Licensed vaccines according to package insert• Licensed vaccines not according to package insert• Unlicensed vaccines
• Medical oversight• CBER review of vaccination programs
3
CC BBEE RR
Approved Licensed Vaccine Programs
Tetanus Toxoid Hepatitis B Rabies Smallpox (Vaccinia) Anthrax Influenza Varicella Material used for immunization must be
licensed or approved by CBER (640.66)
4
CC BBEE RR
Submitting Vaccination Programs
Vaccination programs have been approved by CBER
Vaccination programs are “site-specific” approvals
Contractual arrangements are possible– Perform injections– Collect plasma
5
CC BBEE RR
Submitting Vaccination Programs (cont.)
If using licensed vaccine according to package insert for the:– Injection volume– Administration route– Injection schedule, including boosters– Typically we have reviewed these as a CBE30 Supplement
(601.12(c)) If approved for specific vaccine and changing
vaccine manufacturer but using it according to package insert– If no changes to SOPs – Annual Report (601.12(d))– If revise SOPs to incorporate new package insert – CBE30
Supplement
6
CC BBEE RR
Submitting Vaccination Programs (cont.)
If using licensed vaccine but varying from package insert for injection volume, administration route, injection schedule, including additional boosters– We have typically reviewed these as a PAS Supplement
(601.12(b))– Injection protocol is studied under an IND
If using an unlicensed vaccine– We have typically reviewed these as a PAS Supplement
(601.12(b))– Injection protocol is studied under an IND
7
CC BBEE RR
Submission ContentThe following items have typically been included
in a vaccination program submission: Forms: 356h and 2567 Applicant name and license number Contact name and information Facility name, address, and registration number May reference previously approved SOPs,
forms, labels (include reference number for approvals)
Medical oversight, use of a physician substitute
8
CC BBEE RR
Submission Content (cont.)The following items have typically been
included in a vaccination program submission (cont.):
Vaccination program SOPs that include– Donor selection (606.100(b)(1))– Vaccination procedures (640.66)– Handling of adverse events (606.100(b)(9))
Contractor information Informed consent form (640.61 & 640.72(a)
(3)) Immunization forms (blank) Labels (640.70) Package insert for vaccine
9
CC BBEE RR
Medical Oversight (640.62 and 640.66)
Qualified licensed physician must be on premises when immunizations are performed
Qualified licensed physician must select and schedule the injection
Qualified licensed physician must evaluate donor’s clinical response
Administration of vaccine may be performed by licensed physician or trained person under physician’s supervision
10
CC BBEE RR
Medical Oversight (cont.) Blood Memorandum: Physician Substitutes
(8/15/88) Appropriately trained physician substitute
may perform some of the physician’s duties Physician substitute may administer and
supervise approved vaccine immunization programs (needs additional training)
Physician does not need to be on premises during injection but is still responsible for – Weekly evaluation of immunization records– Approval of injections
11
CC BBEE RR
Medical Oversight (cont.) CBER has approved physician substitute to
assume additional responsibilities in vaccination programs as alternative procedure to 640.66 under the provisions of 640.120 when:– Donors meet all donor suitability criteria– Vaccine is licensed by FDA– Vaccine is administered according to package insert– With this approval, physician substitute may review clinical responses and
schedule injections
Physician still responsible for direction and control of vaccination program and for reviewing adverse reactions
12
CC BBEE RR
SOPs Immunization procedures must be on file at
centers where immunizations are performed (640.66)
Describe medical responsibilities (640.62) Donor selection procedures (606.100(b)(1))
– Donors must meet all donor suitability criteria in 640.63 & 650.65
– Physical exam must occur within 1 week before first immunization unless active donor (640.63(b)(2))
– Medical staff must approve donor’s participate in the program (640.63(a))
13
CC BBEE RR
SOPs (cont.) Vaccination procedures typically include:
– Preparation of injection– Injection volume and schedule, including any boosters
allowed, administration route– When titrations will be performed– Handling and storing of vaccine vials
Adverse reactions procedures (606.100(b)(9))– Vaccine Adverse Event Reporting System (VAERS)– Medical oversight (640.62)– Records maintained (640.72(d))
Proper documentation procedures
14
CC BBEE RR
Contractor Information Name and license number Address and registration number List activities done under contract Where records maintained Describe quality oversight of contractor Both injection facility and collection
center must be approved for vaccination program; both parties are participating in vaccination program
15
CC BBEE RR
Informed ConsentIn addition to the requirements in 640.61, the
approved informed consent should include: Volume, route and schedule of injections Criteria for discontinuation from program Participate in only one immunization
program at a time May not be eligible for other donation
programs Adverse reactions consistent with package
insert Restrictions for female participants
16
CC BBEE RR
Immunization FormsThe immunization forms in approved submissions
have typically included the following information: Donor name, ID number (640.72(b)) Injection preparation – date, employee name,
visual inspection Injection – date, employee name, route, volume,
facility Vaccine - name, lot number, expiration date Physician/physician substitute approval
(640.72(a)(4)) Adverse reactions (640.72(d)) Evidence of QA review (606.100(c))
17
CC BBEE RR
Labels May be made into injectable and
noninjectable products Label must state immunizing antigen
(640.70(a)(7)) Separate label for each vaccine and
intended use (and facility, if applicable)
18
CC BBEE RR
CBER Review of Vaccination Programs
Pre-approval inspection is– Not required if implemented in an approved center– Required if implemented in new center
Vaccination procedures should be consistent with package insert
Approved informed consents typically contain the adverse events described in the package insert
Informed consent includes recommendations in guidance document
Forms contain all information
19
CC BBEE RR
CBER Review of Vaccination Programs (cont.)
Procedures for donor selection, adverse events and medical oversight are consistent with regulations and include all steps to be followed (606.100)
Physician substitute has necessary training (606.20) and if appropriate, 640.120 approval to select and schedule injection
Procedures for handling and storing vaccine vials are consistent with package insert
Labels consistent with 640.70 – Includes the immunizing antigen (640.70(a)(7))
All facilities (including contractors) are FDA registered (607.20) and should have acceptable compliance checks
20
CC BBEE RR
Investigational Vaccine Programs
To distribute Source Plasma in interstate commerce collected as part of an IND program– Source Plasma procedures and labels must be approved– Labels should contain IND number– Collection must occur under cGMPs in facility with approved
vaccination program
IND review may include clinical reviewers from either OBRR and OVRR
Contact Office of Communication, Outreach and Development (OCOD) for information on submitting an IND at 301-827-2000
21
CC BBEE RR
References Blood Memorandum: Physician
Substitutes (8/15/88)– http://www.fda.gov/BiologicsBloodVaccines/GuidanceComp
lianceRegulatoryInformation/OtherRecommendationsforManufacturers/MemorandumtoBloodEstablishments/default.htm
Guidance for Industry: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs (8/8/07)– http://www.fda.gov/BiologicsBloodVaccines/GuidanceComp
lianceRegulatoryInformation/Guidances/Blood/ucm073433.htm
Recommended